Azithromycin and lower respiratory tract infections

Author： Blasi F   Cazzola M   Tarsia P   Cosentini R   Aliberti S   Santus P   Allegra L  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.6, Iss.13, 2005-10, pp. : 2335-2351

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lower Respiratory Tract Infections: Impact on the Workplace

By Birnbaum H.G.  

PharmacoEconomics, Vol. 21, Iss. 10, 2003-01 ,pp. : 749-759

Adis International

Access to resources Recommend Favorite

Therapeutic options for viral lower respiratory tract infections

By  

Inpharma, Vol. 1, Iss. 1395, 2003-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Guide to Selection of Fluoroquinolones in Patients with Lower Respiratory Tract Infections

By Shams Wael E.   Evans Martin E.  

Drugs, Vol. 65, Iss. 7, 2005-01 ,pp. : 949-991

Adis International

Access to resources Recommend Favorite

Novelties in the field of antimicrobial compounds for the treatment of lower respiratory tract infections

By Cazzola M.   Sanduzzi A.   Matera M.G.  

Pulmonary Pharmacology & Therapeutics, Vol. 16, Iss. 3, 2003-06 ,pp. : 131-145

Elsevier

Access to resources Recommend Favorite

Fluoroquinolones are effective and well tolerated in the treatment of adults with lower respiratory tract infections

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 22, Iss. 5, 2006-05 ,pp. : 15-18

Adis International

Access to resources Recommend Favorite